Hepatology
Conference Coverage
DUR-928 shows promise for alcoholic hepatitis
BOSTON – Among 15 patients with severe alcoholic hepatitis, 87% responded to treatment (Lille score less than 0.45).
Conference Coverage
Glecaprevir/pibrentasvir highly effective in HCV genotype 3, among others
BOSTON – Pangenotypic regimen may further progress toward elimination of hepatitis C, investigators say.
From the Journals
Hepatitis C vaccine alters viral trajectory, but fails in chronic infection protection
BOSTON – First-ever randomized study does suggest changes in peak HCV RNA and an HCV RNA change after infection.
Conference Coverage
Fenofibrate fights increased triglycerides in NASH
BOSTON – Patients with advanced fibrosis caused by NASH had limited increase in triglycerides after treatment with varying doses of fenofibrate....
Conference Coverage
Terlipressin reversed hepatorenal syndrome in large prospective study
BOSTON – Durable response linked to less need for early renal replacement therapy, investigators say
From the Journals
Liver abnormalities, disease common in patients with psoriatic arthritis
Patients for whom monitoring of liver function tests is recommended include those with high body mass index, daily alcohol intake, high damaged...
From the Journals
AGA Clinical Practice Update: Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
Individuals with primary sclerosing cholangitis should be regularly checked for hepatobiliary cancers.
From the Journals
Fibrosis severity and cirrhosis drive patient-reported outcomes with NASH
NASH patients with advanced fibrosis have increased quality of life impairment when cirrhosis is included.
From the Journals
Direct-acting antiviral therapy boosts survival for infected HCC patients
Adults with a history of hepatocellular carcinoma had a significantly reduced risk of death after treatment of HCV infections with DAAs.
From the Journals
Increased levels of a bacterial strain may cause nonalcoholic fatty liver disease
Of the patients in the study with NAFLD, 61% carried high alcohol- and medium alcohol-producing Klebsiella pneumoniae, compared with 6.25...
From the Journals
Three factors predict 6-month mortality in patients with DILI
A web-based calculator is now available for clinicians to use in the clinic.